Maryam Lustberg: Diverse site participation is needed to promote equitable access to trials

Maryam Lustberg posted on LinkedIn about recent paper by M. Kelsey Kirkwood et al., titled “State of Geographic Access to Cancer Treatment Trials in the United States: Are Studies Located Where Patients Live?” published on Journal of Clinical Oncology.

Authors: M. Kelsey Kirkwood, Caroline Schenkel, Dominique C. Hinshaw, Suanna S. Bruinooge, David M. Waterhouse, Jeffrey M. Peppercorn, Ishwaria M. Subbiah, Laura A. Levit

“70% of US counties had no reported active trials in 2022

86%of nonmetropolitan counties had no trials versus 44% of metropolitan counties

Effort to facilitate diverse site participation is needed to promote equitable access to trials.”

Source: Maryam Lustberg/LinkedIn

Dr. Maryam Lustberg is the Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, and Chief of Breast Medical Oncology at Yale Cancer Center. She is also an Associate Professor of Medicine (Medical Oncology). She has been recognized for her patient-focused care with awards that include being rated by Forbes as one of the top breast medical oncologists in the nation and named to the Castle Connolly list of “Regional Top Doctors,” and “Exceptional Women in Medicine” for 2020.

Dr. Lustberg is a member of the ASCO Annual Meeting Education Committee, Patient and Survivor Care Education Committee, and Neuropathy Expert Guideline Panel. She is the President and on the Board of Directors for the international organization Multinational Association of Supportive Care in Cancer (MASCC). She serves as an Associate Editor for the Journal of Cancer Survivorship.